Cargando…
Effect of trimetazidine on preventing contrast-induced nephropathy in diabetic patients with renal insufficiency
BACKGROUND: Our study sought to assess the effect of trimetazidine (TMZ) on preventing contrast-induced nephropathy (CIN) in diabetic patients with renal insufficiency. MATERIALS AND METHODS: 106 diabetic patients with renal insufficiency who were undergoing coronary angiography (CAG) and/or percuta...
Autores principales: | Ye, Ziliang, Lu, Haili, Su, Qiang, Xian, Xinhua, Li, Lang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731977/ https://www.ncbi.nlm.nih.gov/pubmed/29254267 http://dx.doi.org/10.18632/oncotarget.19519 |
Ejemplares similares
-
Clinical effect of trimetazidine on prevention of contrast-induced nephropathy in patients with renal insufficiency: An updated systematic review and meta-analysis
por: Ye, Ziliang, et al.
Publicado: (2017) -
Effect of ligustrazine on preventing contrast-induced nephropathy in patients with unstable angina
por: Ye, Ziliang, et al.
Publicado: (2017) -
Comparing Trimetazidine with Allopurinol in Prevention of Contrast Induced Nephropathy After Coronary Angiography
por: Galal, Haitham, et al.
Publicado: (2020) -
The effect of alprostadil on preventing contrast-induced nephropathy for percutaneous coronary intervention in diabetic patients: A systematic review and meta-analysis
por: Ye, Ziliang, et al.
Publicado: (2016) -
Trimetazidine reduces contrast-induced nephropathy in patients with renal insufficiency undergoing coronary angiography and angioplasty: A systematic review and meta-analysis (PRISMA)
por: Heshmatzadeh Behzadi, Ashkan, et al.
Publicado: (2021)